Results

Total Results: 2,462 records

Showing results for "test".
Users also searched for: colon

301. Meta-Analytic Statistical Inferences for Continuous Measure Outcomes as a Function of Effect Size Metric and Other Assumptions | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/statistical-inference/research
     April 10, 2013 - within-study observed measure variances for experimental and control groups and at pretest and post-test … (ratios: 1:1, 2:1, and 4:1); (4) the post-test mean of each pseudo experimental group to achieve 3 parametric

302. Systematic Review of Calcineurin Inhibitors for Kidney Transplant | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/calcineurin-inhibitor/research-protocol
     October 14, 2014 - below in separate categories pertaining to publication type, study design, patient characteristics, test … Addressing challenges in genetic test evaluation. … Methods guide for medical test reviews [AHRQ Publication No. 12-EHC017]. … described in sufficient detail to permit replication of the test? … Internal validity and reporting adequacy: Has the reproducibility of the test when performed multiple

303. S89 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/s89.pdf
     October 01, 2007 - In the current study of MCV, we specified an alpha of 0.05 for a 1-sided test. … †One-sided test; when relative risk �1, the log likelihood ratio was set to 0. … †One-sided test; when relative risk �1, the log likelihood ratio was set to 0. … A maximized sequential probability ratio test for vaccine and drug safety surveillance. … A maximized sequential probability ratio test for drug and vaccine adverse event surveillance.

304. Topic Suggestion Description | Effective Health Care Program
     effectivehealthcare.ahrq.gov/get-involved/nominated-topics/for-patients-including-both-children-and-adult-subgroup-comparisons-with-type-1-diabetes-what-is-the-comparitive-differences-in-hba1c-levels-when-comparing-various-treatment-options-including-multiple-daily-injections-insulin
     July 19, 2009 - 130.2 KB] Briefly describe a specific question, or set of related questions, about a health care test … prescription from their treating physician but once they retired, Medicare required a fasting blood test … with diabetes, a laboratory technician assigning a range and creating a result from this antiquated test

305. Can screening among the general adult male population for elevated PCA3 (also known as DD3) gene expression, to identify those at risk for prostate cancer who may be candidates for prostate biopsy, reduce morbidity and mortality? | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/get-involved/nominated-topics/can-screening-among-the-general-adult-male-population-for-elevated-pca3-also-known-as-dd3-gene-expression-to-identify-those-at-risk-for-prostate-cancer-who-may-be-candidates-for-prostate-biopsy-reduce-morbidity-and-mortality
     July 29, 2010 - 160 KB] Briefly describe a specific question, or set of related questions, about a health care test

306. Evidence Report on the (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/c-diff-infections_research-protocol.pdf
     May 24, 2010 - for toxins if the first step test is positive. … Physicians may not always be sufficiently educated as to which diagnostic test is best to use and how … best to resolve a suspected false negative result (e.g., evidence suggests retesting with the same test … • Outcomes for each question: Diagnostic Test Outcomes 1. Sensitivity 2. Specificity 3. … • Timing: Diagnostic testing: time to test http://www.effectivehealthcare.ahrq.gov/�

307. Gout Executive-2016 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/gout_executive-2016.pdf
     January 01, 2016 - However, if no such studies could be identified for a diagnostic test of interest, studies were also … Patient-level factors that influence test behavior have also been understudied. … Assessing risk of bias as a domain of quality in medical test studies. … In: Methods Guide for Medical Test Reviews. AHRQ Publication No. 12-EHC017. … Methods Guide for Medical Test Reviews. AHRQ Publication No. 12-EHC017.

308. Disposition of Comments for Use of Natriuretic Peptide Measurement in the Management of Heart Failure (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/heart-failure-natriuretic-peptide_disposition-comments.pdf
     November 20, 2013 - General In point of fact, this document may wish to make the comment that like no other diagnostic test … Simply adding another test because it has excellent rule out diagnostic accuracy does not make sense … But is ruling out the purpose the test is used for? … What will happen to test positive patients and test negative patients? … The length of follow up was unrestricted – there was not limit on how long after the index test the

309. What are the comparative diagnostic accuracy, diagnostic thinking, therapeutic, and patient outcome efficacy of non-invasive tests for the risk stratification of patients with coronary artery disease? | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/get-involved/nominated-topics/what-are-the-comparative-diagnostic-accuracy-diagnostic-thinking-therapeutic-and-patient-outcome-efficacy-of-non-invasive-tests-for-the-risk-stratification-of-patients-with-coronary-artery-disease
     February 27, 2012 - 1.2 MB] Briefly describe a specific question, or set of related questions, about a health care test

310. Key Questions 1. Does routine preoperative testing compared to no testing or alternative testing strategies improve outcomes (such as surgical complications, other morbidity, and mortality) among patients undergoing elective surgery? 2.… | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/get-involved/nominated-topics/key-questions-1-does-routine-preoperative-testing-compared-to-no-testing-or-alternative-testing-strategies-improve-outcomes-such-as-surgical-complications-other-morbidity-and-mortality-among-patients-undergoing-elective-surg

311. End of Life Issues | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/health-topics/end-life-issues
     May 17, 2010 - Testing Cancer Quality Measures for End-of-Life Care Research Report Archived May 17, 2010 Eliciting Patients’ Values and Preferences in Decision Making (Session II) White Paper September 30, 2011 Developing Quality Indicators for Cancer End-of-Life Care: Proceedings From …

312. About the Evidence Synthesis Process | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/about/epc/evidence-synthesis
     evidence—from clinical research studies, clinical trials, and other research studies—on the effectiveness of a test

313. Assessing the Risk of Bias in Systematic Reviews of Health Care Interventions (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/ehc-presentation-risk-of-bias.pdf
     December 01, 2017 - Pilot test and train 3. Perform Assessment of Risk of Bias of Individual Studies 4. … Develop Protocol Pilot test and train Perform Assessment of Risk of Bias of Individual Studies Use Risk … Pilot Test and Train • Determine composition of the review team ► Dual independent assessment of risk … of bias with an unbiased reconciliation method • Reviewers must be trained • Pilot test assessment … Pilot Test and Train Stage 3.

314. Genetic Testing for Developmental Disabilities, Intellectual Disability, and Autism Spectrum Disorder | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/genetic-testing-developmental-disabilities/technical-brief
     June 30, 2015 - We also identified one test cleared by the U.S. Food and Drug Administration.

315. Benefits and Harms of Routine Preoperative Testing: Comparative Effectiveness | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/preoperative-testing/research
     January 29, 2014 - Current Page Topic Timeline Feb. 10, 2011 Topic Suggestion May. 14, 2013 Research Protocol Jan. 29, 2014 Systematic Review Apr. 28, 2014 Disposition of Comments Report Benefits and Harms of Routine Preoperative Testing: Comparative Effectiveness Systematic Review Archived January 29, 2014 Web Version [NLM Site] Do…

316. For women, when comparing noninvasive testing,which testing method (echocardiography, MIBI-SPECT, pharmacological testing, etc.) is more accurate in diagnosing coronary artery disease. There has been inadequate studies done on women for… | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/get-involved/nominated-topics/for-women-when-comparing-noninvasive-testingwhich-testing-method-echocardiography-mibi-spect-pharmacological-testing-etc-is-more-accurate-in-diagnosing-coronary-artery-disease-there-has-been-inadequate-studies-done-on-women-

317. Data Points #15: Prognostic factor testing among older women with ductal carcinoma in situ and early invasive breast cancer | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/dcis-prognostic-tests/research
     September 13, 2012 - Data Points #15: Prognostic factor testing among older women with ductal carcinoma in situ and early invasive breast cancer Research Report September 13, 2012 Web Version [NLM Site] Download Main Document PDF 797.2 KB This report is available in PDF (797 kB) form only. People using assistive technolog…

318. Topic 0505 Genetic Testing for Developmental Diseases NSD FINAL_SJ (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND-0594-131115.pdf
     March 13, 2013 - Topic 0505 Genetic Testing for Developmental Diseases NSD FINAL_SJ § Genetic Testing for Developmental Diseases Nomination Summary Document …

319. Data Points 15: Breast Cancer Diagnostic Workup: Prognostic factor testing among older women with ductal carcinoma in situ and early invasive breast cancer (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/dcis-prognostic-tests_research.pdf
     August 22, 2012 - analysis showed that our claims-based measure was, although slightly lower, close to SEER rates of test … Women with invasive disease have higher rates of lymph node test- ing overall than women with DCIS, and

320. Version 2_Risk of Reinfection From SARS-CoV-2 -- An Update of an Antibody Response Following SARS-CoV-2 Infection and Implications for Immunity: A Living Rapid Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/version-2-risk-of-reinfection-from-SARSCoV2_0.pdf
     December 31, 2022 - Nine studies used antibody test results to assign patients to the “positive” or “negative” cohorts;23 … , 26, 28, 30, 31, 33, 37-39 three used a combination of antibody test results and PCR;9, 29, 36 and … 13 days after the initial positive PCR test.14 A large proportion of patients in the dataset … This finding applies only to people who have had a negative antibody test (e.g., for surveillance in … Association of SARS-CoV-2 Seropositive Antibody Test With Risk of Future Infection.